MAP4K1
MAP4K1, also known as HPK1, is a serine/threonine-protein kinase of the STE20 subfamily that contributes to the response to environmental stress. It acts upstream of the JUN N-terminal pathway and activates Hippo signalling. Browse Assay Genie's current range of MAP4K1 research reagents below, or read on for the biology behind the target.
MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1) is a serine/threonine-protein kinase that plays a role in the response to environmental stress. It appears to act upstream of the JUN N-terminal pathway, and NCBI Gene annotates it as enabling ATP binding and MAP kinase kinase kinase kinase activity, with involvement in the JNK cascade, protein phosphorylation and the cellular response to phorbol 13-acetate 12-myristate.
The protein is an activator of the Hippo signalling pathway, which has a pivotal role in organ size control and tumour suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to, and are partially redundant with, STK3/MST2 and STK4/MST2 in phosphorylating and activating LATS1/2, which establishes them as components of the expanded Hippo pathway. MAP4K1 may also play a role in haematopoietic lineage decisions and growth regulation. Together with CLNK, it enhances CD3-triggered activation of T-cells and the subsequent production of IL-2.
The MAP4K1 gene belongs to the MAP4K family (GCK-I subfamily) and encodes a member of the protein kinase superfamily, STE Ser/Thr protein kinase family, STE20 subfamily. The kinase is also known by the alias HPK1, and the mouse ortholog is Map4k1. NCBI Gene reports that the protein is located in the membrane.
MAP4K1 phosphorylates and activates LATS1/2 in parallel to STK3 and STK4, making it a component of the expanded Hippo pathway.
With CLNK, MAP4K1 enhances CD3-triggered T-cell activation and subsequent IL-2 production.
The kinase responds to environmental stress and appears to act upstream of the JUN N-terminal pathway.
MAP4K1 may contribute to haematopoietic lineage decisions and growth regulation, and it restricts proliferation through Hippo signalling.
MAP4K1 is a serine/threonine kinase that contributes to the response to environmental stress and appears to act upstream of the JUN N-terminal pathway. It also activates Hippo signalling by helping to phosphorylate LATS1/2, and with CLNK it enhances CD3-triggered T-cell activation and IL-2 production.
Yes. HPK1 is an alias for MAP4K1, whose full name is mitogen-activated protein kinase kinase kinase kinase 1. HGNC places the gene in the MAP4K family (GCK-I subfamily). Literature and reagent descriptions may use either name, so it helps to search both.
A mouse ortholog, Map4k1, is recorded for this gene. The protein belongs to the STE20 subfamily of the STE Ser/Thr protein kinase family. For any product, check the datasheet for its validated reactivity before planning cross-species work.
Other MAP4K family members and MAP kinase cascade components with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92918; product specifications from Assay Genie datasheets.